NGP 555, a γ-secretase modulator, shows a beneficial shift in the ratio of amyloid biomarkers in human cerebrospinal fluid at safe doses.

Kounnas MZ, Durakoglugil MS, Herz J, Comer WT

Open source

DOI
10.1016/j.trci.2019.06.006
Published
2019
Container
Alzheimer's & dementia (New York, N. Y.)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.trci.2019.06.006,
  title = {NGP 555, a γ-secretase modulator, shows a beneficial shift in the ratio of amyloid biomarkers in human cerebrospinal fluid at safe doses.},
  author = {Kounnas MZ and Durakoglugil MS and Herz J and Comer WT},
  year = {2019},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  doi = {10.1016/j.trci.2019.06.006},
  url = {https://doi.org/10.1016/j.trci.2019.06.006}
}

RIS

TY  - JOUR
TI  - NGP 555, a γ-secretase modulator, shows a beneficial shift in the ratio of amyloid biomarkers in human cerebrospinal fluid at safe doses.
AU  - Kounnas MZ
AU  - Durakoglugil MS
AU  - Herz J
AU  - Comer WT
PY  - 2019
JO  - Alzheimer's & dementia (New York, N. Y.)
DO  - 10.1016/j.trci.2019.06.006
UR  - https://doi.org/10.1016/j.trci.2019.06.006
ER  -

APA

MZ, K., MS, D., J, H., & WT, C. (2019). NGP 555, a γ-secretase modulator, shows a beneficial shift in the ratio of amyloid biomarkers in human cerebrospinal fluid at safe doses.. Alzheimer's & dementia (New York, N. Y.). https://doi.org/10.1016/j.trci.2019.06.006

Source records